Press Releases Eli Lilly and Company Deutsche Boerse AG

Equities

LLY

US5324571083

Market Closed - Deutsche Boerse AG Other stock markets 11:45:05 2024-05-31 EDT			5-day change	1st Jan Change
754.7 ^EUR	+0.12%		+1.41%	+43.34%

02:00pm	Eli Lilly and Company Announces Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting	CI
05-30	Danish Government Implements Stricter Subsidy Rules for Diabetes Drugs	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER	05-31	AQ
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases	05-29	PR
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	05-29	AQ
Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference	05-28	PR
Major manufacturing investment to support API production for tirzepatide	05-27	AQ
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro	05-24	AQ
Eli Lilly and : 2015 Global Health Programs Report	05-24	PU
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines	05-24	PR
Keysight Technologies, Nordson fall; Eli Lilly, Lam Research rise, Tuesday, 5/21/2024	05-21	AQ
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	05-21	AQ
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin	05-16	PR
Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer	05-15	PR
Eli Lilly and : Lilly Update on Mounjaro® and Zepbound® (tirzepatide) Compounding Litigation	05-14	PU
Eli Lilly and : Lilly Statement on FDA Advisory Committee Meeting on Donanemab for Early Symptomatic Alzheimer’s Disease	05-07	PU
Lilly Declares Second-Quarter 2024 Dividend	05-06	PR
Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024	04-30	AQ
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues	04-30	AQ
Eli Lilly and : Q1 Earnings 2024 Press Release	04-30	PU
Eli Lilly and : Q1 Earnings 2024 Earnings Presentation	04-30	PU
Lilly: Q1 Earnings Snapshot	04-30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 02:47 pm